Featured Research

from universities, journals, and other organizations

Vaccine For Cytomegalovirus Has Promise

Date:
June 4, 1997
Source:
Johns Hopkins Children's Center
Summary:
A vaccine for cytomegalovirus was found to be well tolerated and highly immunogenic in toddlers, according to research at Eastern Virginia Medical School. CMV can cause mononucleosis-type illness, organ rejection, and birth defects.

NORFOLK, Va. -- Researchers at Eastern Virginia Medical School are studying a vaccine that may decrease transmission of cytomegalovirus (CMV) from children to adults.

CMV is a virus that may cause mononucleosis-type illness in healthy adults, severe infections in persons whose immune systems are impaired, organ rejection in transplant recipients and birth defects in infants born to mothers infected during pregnancy.

Douglas K. Mitchell, M.D., assistant professor of pediatrics at EVMS, led the investigation, which was carried out at the Center for Pediatric Research, a joint program of EVMS and Children's Hospital of The King's Daughters.

Mitchell's research, which involved toddlers, used a subunit vaccine combined with a novel adjuvant. The vaccine was produced by Chiron Vaccines, Emeryville, CA. The vaccine was well tolerated and highly immunogenic in the toddlers.


Story Source:

The above story is based on materials provided by Johns Hopkins Children's Center. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Children's Center. "Vaccine For Cytomegalovirus Has Promise." ScienceDaily. ScienceDaily, 4 June 1997. <www.sciencedaily.com/releases/1997/06/970604091714.htm>.
Johns Hopkins Children's Center. (1997, June 4). Vaccine For Cytomegalovirus Has Promise. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/1997/06/970604091714.htm
Johns Hopkins Children's Center. "Vaccine For Cytomegalovirus Has Promise." ScienceDaily. www.sciencedaily.com/releases/1997/06/970604091714.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
New Drug Could Reduce Cardiovascular Deaths

New Drug Could Reduce Cardiovascular Deaths

Newsy (Aug. 30, 2014) The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins